Follow The Filings

PHI PLDT

PLDT earnings company data as of 4:48 AM ET 10/23

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS 0.58 — —
Rev — — —
FY2026 Q2 13 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PHI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PHI insider trades
  • None no insider bought on the open market
  • $455K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Manuel Velez Pangilinan CEO
    Sale
    $36K 2,000 shares at $18.04 0.5% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  2. Manuel Velez Pangilinan CEO
    Sale
    $36K 2,000 shares at $18.15 0.5% of stake
    Traded Sep 2 Filed Sep 3
    ↗
  3. Manuel Velez Pangilinan CEO
    Sale
    $39K 2,000 shares at $19.36 0.5% of stake
    Traded Aug 24 Filed Aug 25
    ↗
  4. Marilyn Azaula Victorio-Aquino Senior VP & Sr. Legal Advisor
    Sale
    $242K 12,700 shares at $19.09 24% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  5. Alfredo Santos Panlilio Director
    Sale
    $102K 4,505 shares at $22.64 60% of stake
    Traded Apr 10 Filed Apr 13
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
20-F Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.